Skip to main content

Articles Tagged With:

  • Market Updates

    Physical examinations can provide critical information unavailable by other means to help patients experiencing urgent cardiac care issues, such as heart attack or unstable chest pain, according to research conducted at the Cleveland Clinic (Cleveland, Ohio).
  • Personnel File

    CardioGenesis (Foothill Ranch, California) reported that Chairman and Chief Executive Officer Michael Quinn has resumed the position of president, effective immediately, replacing Darrell Eckstein, who left the company to pursue other interests.
  • Product Pipeline

    In what constitutes a new phase in the development of its technology for the heart assist market, Thoratec (Pleasanton, California) last month reported the start of its Phase I safety trial for its HeartMate II axial-flow left ventricular assist device.
  • Full December 1, 2003 Issue in PDF

  • Optimizer II seeks a niche in weaponry against heart failure

    The armamentarium of devices to shock and assist the pumping action of the heart seems to have grown rather full, with seemingly little room for new ones. Pacemakers, defibrillators, ventricular assist devices and even the artificial heart have provided an increasing range of technologies for supporting and retaining important functions and even substituting for the heart.
  • 'Advances in Cardiovascular Technology Vol. 2’ available

    Advances in Cardiovascular Technology: Emerging Markets for the 21st Century, Vol. 2, the newest sourcebook from the publishers of Cardiovascular Device Update and The BBI Newsletter, has just been released.
  • Report from Europe

    The UK Department of Health has unveiled a new framework directed toward helping improve services for those suffering from heart disease. A new toolkit, the National Workforce Competence Framework for Coronary Heart Disease, sets out the core skills needed by National Health Service (NHS) staff to deliver the best services for those with, or at risk of, coronary disease. The skills covered concentrate of the priority areas of prevention, heart failure and rehabilitation.
  • Acquisitions

    Andromed (Montreal, Quebec) said that it plans to divest its Androfact system in order to refocus its activities on its Androsonix technology platform while developing additional commercial partners for its Androscope family of products.
  • Mist vaccine appears to be as effective as flu shot

    Influenza information from the Centers for Disease Control and Prevention (CDC) includes the following answers to common questions about the new live attenuated influenza vaccine (LAIV).
  • Report paints a dark picture of SARS in U.S.

    With visions of overrun, bankrupt hospitals and workers dying or refusing to treat patients, a recent government-commissioned study of an epidemic of severe acute respiratory syndrome (SARS) in the United States had everything but a nightmarish cover painting by Hieronymus Bosch.